Yuxiang Chen

721 total citations
26 papers, 367 citations indexed

About

Yuxiang Chen is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Yuxiang Chen has authored 26 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Surgery. Recurrent topics in Yuxiang Chen's work include Circular RNAs in diseases (3 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Cancer therapeutics and mechanisms (2 papers). Yuxiang Chen is often cited by papers focused on Circular RNAs in diseases (3 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Cancer therapeutics and mechanisms (2 papers). Yuxiang Chen collaborates with scholars based in China, United States and United Kingdom. Yuxiang Chen's co-authors include Jingfeng Zhao, Zhang Yang-de, Jian Li, Jinbang Li, Longmei Cai, Xin Li, Xiaoming Lyu, Hongbing Cai, Weibo Chen and Junsheng Yang and has published in prestigious journals such as PLoS ONE, Oncotarget and Bioorganic & Medicinal Chemistry.

In The Last Decade

Yuxiang Chen

22 papers receiving 362 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Yuxiang Chen 166 154 132 58 54 26 367
Xiaoju Shi 126 0.8× 128 0.8× 69 0.5× 57 1.0× 77 1.4× 35 415
Huajie Zong 219 1.3× 114 0.7× 160 1.2× 29 0.5× 42 0.8× 10 317
Malee Warnnissorn 135 0.8× 109 0.7× 130 1.0× 52 0.9× 54 1.0× 32 371
Jadzia Tin-Tsen Chou 157 0.9× 150 1.0× 74 0.6× 97 1.7× 60 1.1× 15 421
Chaoxi Zhou 188 1.1× 80 0.5× 122 0.9× 31 0.5× 39 0.7× 32 318
Tianliang Xia 241 1.5× 119 0.8× 125 0.9× 44 0.8× 22 0.4× 21 366
Houyu Ju 214 1.3× 162 1.1× 146 1.1× 69 1.2× 30 0.6× 28 415
Xueke Qian 276 1.7× 132 0.9× 258 2.0× 79 1.4× 20 0.4× 14 502
Shaocong Wu 255 1.5× 199 1.3× 130 1.0× 96 1.7× 23 0.4× 14 454
Hongze Chen 319 1.9× 209 1.4× 214 1.6× 83 1.4× 131 2.4× 21 594

Countries citing papers authored by Yuxiang Chen

Since Specialization
Citations

This map shows the geographic impact of Yuxiang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuxiang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuxiang Chen more than expected).

Fields of papers citing papers by Yuxiang Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuxiang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuxiang Chen. The network helps show where Yuxiang Chen may publish in the future.

Co-authorship network of co-authors of Yuxiang Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yuxiang Chen. A scholar is included among the top collaborators of Yuxiang Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuxiang Chen. Yuxiang Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yuxiang, et al.. (2024). Impact of Physical Activity Frequency, Duration, and Intensity on Senile Cataract Risk: A Mendelian Randomization Study. Translational Vision Science & Technology. 13(5). 26–26.
2.
Zheng, Zhaohui, Changxing Li, Qi Wang, et al.. (2024). Emodin combined with 5‐aminolevulinic acid photodynamic therapy inhibits condyloma acuminate angiogenesis by targeting SerRS. Journal of Cellular and Molecular Medicine. 28(19). e70122–e70122.
4.
Lv, Ya, Deming Chen, Xinyi Tian, et al.. (2023). Protectin conjugates in tissue regeneration 1 alleviates sepsis-induced acute lung injury by inhibiting ferroptosis. Journal of Translational Medicine. 21(1). 293–293. 30 indexed citations
5.
Chen, Yuxiang, et al.. (2023). Evaluation of a novel lyophilized-pellet-based 2019-nCoV nucleic acid detection kit for the diagnosis of COVID-19. PLoS ONE. 18(10). e0292902–e0292902. 1 indexed citations
6.
Chen, Yuxiang, Lihua Chen, Ruijin Hong, et al.. (2023). Effects of percutaneous coronary intervention and diabetes mellitus on short- and long-term prognosis assessed by the three-vessel quantitative flow ratio. Diabetes Research and Clinical Practice. 206. 111013–111013. 2 indexed citations
8.
Zhu, Li, Yuxiang Chen, Wei Ding, et al.. (2022). Caspase-3/Treg and PI3K/AKT/mTOR pathway is involved in Liver Ischemia Reperfusion Injury (IRI) protection by everolimus. Transplant Immunology. 71. 101541–101541. 3 indexed citations
9.
Chen, Yuxiang, et al.. (2021). Design, synthesis and anti-fibrosis evaluation of imidazo[1,2–a]pyridine derivatives as potent ATX inhibitors. Bioorganic & Medicinal Chemistry. 46. 116362–116362. 3 indexed citations
10.
Chen, Yuxiang, Chi Liu, Shaomi Zhu, et al.. (2021). PD-1/PD-L1 immune checkpoint blockade-based combinational treatment: Immunotherapeutic amplification strategies against colorectal cancer. International Immunopharmacology. 96. 107607–107607. 18 indexed citations
11.
Li, Tong, et al.. (2021). Nucleoside and Non-Nucleoside DOT1L Inhibitors: Dawn of MLLrearranged Leukemia. Mini-Reviews in Medicinal Chemistry. 21(11). 1337–1350. 5 indexed citations
12.
Li, Wei, Tianming Zhao, Yuxiang Chen, et al.. (2020). Fragment-based modification of 2,4-diarylaminopyrimidine derivatives as ALK and ROS1 dual inhibitors to overcome secondary mutants. Bioorganic & Medicinal Chemistry. 28(20). 115719–115719. 10 indexed citations
13.
Chen, Yuxiang, et al.. (2020). Pyrroformyl-containing 2,4-diaminopyrimidine derivatives as a new optimization strategy of ALK inhibitors combating mutations. Bioorganic & Medicinal Chemistry. 28(20). 115715–115715. 8 indexed citations
14.
Bao, Yongjin, Junsheng Yang, Yunfei Duan, et al.. (2020). The C-reactive protein to albumin ratio is an excellent prognostic predictor for gallbladder cancer. BioScience Trends. 14(6). 428–435. 28 indexed citations
15.
Chen, Yuxiang, et al.. (2019). Measurement of Specific Mycobacterial Mistranslation Rates with Gain-of-function Reporter Systems. Journal of Visualized Experiments. 2 indexed citations
16.
Li, Jing, Lihua Zhao, Xin Huang, et al.. (2016). Polyethyleneglycol-Modified Poly(<I>d</I>, <I>l</I>-lactideco-glycolide) Loaded Resveratrol Nanoparticles Characterization and Their Anti-cancer Activities. Journal of Nanoscience and Nanotechnology. 16(9). 9477–9481. 3 indexed citations
17.
Li, Jian, et al.. (2011). Overexpression of miR-22 reverses paclitaxel-induced chemoresistance through activation of PTEN signaling in p53-mutated colon cancer cells. Molecular and Cellular Biochemistry. 357(1-2). 31–38. 83 indexed citations
18.
Yu, Shuyi, et al.. (2008). A critical role of CCR7 in invasiveness and metastasis of SW620 colon cancer cell in vitro and in vivo. Cancer Biology & Therapy. 7(7). 1037–1043. 33 indexed citations
19.
Cochran, David J., et al.. (2007). Perceived and Actual Grasp Forces on Cylindrical Handles. Human Factors The Journal of the Human Factors and Ergonomics Society. 49(2). 292–299. 8 indexed citations
20.
Yang, Yongjia, Jihong Guo, Zheng Liu, et al.. (2006). A locus for autosomal dominant accessory auricular anomaly maps to 14q11.2–q12. Human Genetics. 120(1). 144–147. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026